nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—PDE5A—blood plasma—schizophrenia	0.0528	0.143	CbGeAlD
Tadalafil—PDE11A—endocrine gland—schizophrenia	0.0441	0.12	CbGeAlD
Tadalafil—PDE11A—brain—schizophrenia	0.0316	0.0855	CbGeAlD
Tadalafil—CYP3A4—urine—schizophrenia	0.0315	0.0855	CbGeAlD
Tadalafil—PDE11A—Nitric oxide stimulates guanylate cyclase—NOS1—schizophrenia	0.0312	0.0494	CbGpPWpGaD
Tadalafil—PDE5A—forebrain—schizophrenia	0.0289	0.0784	CbGeAlD
Tadalafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS1—schizophrenia	0.0278	0.044	CbGpPWpGaD
Tadalafil—PDE5A—telencephalon—schizophrenia	0.0266	0.0721	CbGeAlD
Tadalafil—PDE5A—gonad—schizophrenia	0.0222	0.0602	CbGeAlD
Tadalafil—PDE5A—blood—schizophrenia	0.0193	0.0524	CbGeAlD
Tadalafil—CYP3A4—Lidocaine metabolism—CYP1A2—schizophrenia	0.0193	0.0306	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—TAAR6—schizophrenia	0.0193	0.0305	CbGpPWpGaD
Tadalafil—PDE5A—endocrine gland—schizophrenia	0.0168	0.0455	CbGeAlD
Tadalafil—CYP3A4—blood plasma—schizophrenia	0.0165	0.0446	CbGeAlD
Tadalafil—PDE11A—G alpha (s) signalling events—HTR6—schizophrenia	0.0161	0.0255	CbGpPWpGaD
Tadalafil—PDE5A—nervous system—schizophrenia	0.0157	0.0426	CbGeAlD
Tadalafil—PDE11A—Platelet homeostasis—ATP2A2—schizophrenia	0.0152	0.0241	CbGpPWpGaD
Tadalafil—PDE5A—central nervous system—schizophrenia	0.0151	0.041	CbGeAlD
Tadalafil—PDE5A—cerebellum—schizophrenia	0.0148	0.0401	CbGeAlD
Tadalafil—PDE5A—Platelet homeostasis—ATP2A2—schizophrenia	0.0135	0.0215	CbGpPWpGaD
Tadalafil—PDE11A—Platelet homeostasis—NOS1—schizophrenia	0.0121	0.0192	CbGpPWpGaD
Tadalafil—PDE5A—brain—schizophrenia	0.012	0.0325	CbGeAlD
Tadalafil—PDE11A—G alpha (s) signalling events—PDE4B—schizophrenia	0.0118	0.0186	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—ADORA2A—schizophrenia	0.0112	0.0178	CbGpPWpGaD
Tadalafil—PDE5A—Platelet homeostasis—NOS1—schizophrenia	0.0108	0.0172	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—NPS—schizophrenia	0.00959	0.0152	CbGpPWpGaD
Tadalafil—PDE11A—Platelet homeostasis—PLA2G4A—schizophrenia	0.00945	0.015	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—DRD1—schizophrenia	0.00941	0.0149	CbGpPWpGaD
Tadalafil—CYP3A4—Farnesoid X Receptor  Pathway—SLC27A5—schizophrenia	0.00904	0.0143	CbGpPWpGaD
Tadalafil—PDE5A—Platelet homeostasis—PLA2G4A—schizophrenia	0.00842	0.0133	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—HTR7—schizophrenia	0.00824	0.0131	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—DGKI—schizophrenia	0.00782	0.0124	CbGpPWpGaD
Tadalafil—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—schizophrenia	0.00709	0.0112	CbGpPWpGaD
Tadalafil—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—schizophrenia	0.00705	0.0112	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—DGKI—schizophrenia	0.00697	0.011	CbGpPWpGaD
Tadalafil—CYP3A4—blood—schizophrenia	0.00603	0.0164	CbGeAlD
Tadalafil—CYP3A4—Aflatoxin B1 metabolism—GSTM1—schizophrenia	0.00544	0.00861	CbGpPWpGaD
Tadalafil—CYP3A4—endocrine gland—schizophrenia	0.00523	0.0142	CbGeAlD
Tadalafil—PDE11A—Hemostasis—MAG—schizophrenia	0.00504	0.00799	CbGpPWpGaD
Tadalafil—CYP3A4—Codeine and Morphine Metabolism—ABCB1—schizophrenia	0.00503	0.00797	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—DGKI—schizophrenia	0.00494	0.00783	CbGpPWpGaD
Tadalafil—CYP3A4—nervous system—schizophrenia	0.0049	0.0133	CbGeAlD
Tadalafil—CYP3A4—central nervous system—schizophrenia	0.00471	0.0128	CbGeAlD
Tadalafil—PDE11A—Hemostasis—IL3RA—schizophrenia	0.00449	0.00712	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—MAG—schizophrenia	0.00449	0.00712	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—DGKI—schizophrenia	0.00449	0.00711	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PPP1R1B—schizophrenia	0.00411	0.00651	CbGpPWpGaD
Tadalafil—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—schizophrenia	0.00405	0.00641	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IL3RA—schizophrenia	0.004	0.00634	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—GRM2—schizophrenia	0.00395	0.00626	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—TAAR6—schizophrenia	0.00395	0.00626	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—FZD3—schizophrenia	0.00382	0.00605	CbGpPWpGaD
Tadalafil—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—schizophrenia	0.00366	0.0058	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—NGEF—schizophrenia	0.00366	0.00579	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—GRM2—schizophrenia	0.00359	0.00569	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—TAAR6—schizophrenia	0.00359	0.00569	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PPP3CC—schizophrenia	0.00359	0.00569	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—NTS—schizophrenia	0.00357	0.00566	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—FGA—schizophrenia	0.00349	0.00554	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—ATP2A2—schizophrenia	0.0034	0.00539	CbGpPWpGaD
Tadalafil—CYP3A4—Xenobiotics—CYP2D6—schizophrenia	0.00339	0.00536	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—GRM3—schizophrenia	0.00336	0.00532	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—RGS4—schizophrenia	0.00336	0.00532	CbGpPWpGaD
Tadalafil—CYP3A4—Estrogen metabolism—CYP1A2—schizophrenia	0.00333	0.00528	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—NGEF—schizophrenia	0.00332	0.00526	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—HTR6—schizophrenia	0.0033	0.00523	CbGpPWpGaD
Tadalafil—CYP3A4—Tamoxifen metabolism—CYP2D6—schizophrenia	0.00326	0.00516	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—NTS—schizophrenia	0.00325	0.00514	CbGpPWpGaD
Tadalafil—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—schizophrenia	0.00319	0.00505	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—FGA—schizophrenia	0.00311	0.00493	CbGpPWpGaD
Tadalafil—CYP3A4—Xenobiotics—CYP1A2—schizophrenia	0.00306	0.00485	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—RGS4—schizophrenia	0.00305	0.00483	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—GRM3—schizophrenia	0.00305	0.00483	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ATP2A2—schizophrenia	0.00303	0.00481	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HTR6—schizophrenia	0.003	0.00475	CbGpPWpGaD
Tadalafil—CYP3A4—Tamoxifen metabolism—CYP1A2—schizophrenia	0.00294	0.00467	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CHRM1—schizophrenia	0.00291	0.00462	CbGpPWpGaD
Tadalafil—CYP3A4—Tryptophan metabolism—TPH1—schizophrenia	0.00287	0.00455	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—IL3RA—schizophrenia	0.00284	0.0045	CbGpPWpGaD
Tadalafil—CYP3A4—Estrogen metabolism—COMT—schizophrenia	0.00279	0.00442	CbGpPWpGaD
Tadalafil—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—schizophrenia	0.00275	0.00436	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—NOS1—schizophrenia	0.00272	0.00431	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—GRM5—schizophrenia	0.00271	0.00429	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—DGKI—schizophrenia	0.00265	0.0042	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CHRM1—schizophrenia	0.00265	0.00419	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26B1—schizophrenia	0.0026	0.00413	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL3RA—schizophrenia	0.00258	0.00408	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP26B1—schizophrenia	0.00257	0.00407	CbGpPWpGaD
Tadalafil—CYP3A4—Estrogen metabolism—GSTM1—schizophrenia	0.00255	0.00405	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CCK—schizophrenia	0.00248	0.00392	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—GRM5—schizophrenia	0.00246	0.0039	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—NOS1—schizophrenia	0.00243	0.00384	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PPP1R1B—schizophrenia	0.00243	0.00384	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PDE4B—schizophrenia	0.00241	0.00382	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CCKAR—schizophrenia	0.00238	0.00376	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—ADORA2A—schizophrenia	0.0023	0.00365	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FZD3—schizophrenia	0.00225	0.00357	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCK—schizophrenia	0.00225	0.00356	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PDE4B—schizophrenia	0.00219	0.00347	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCKAR—schizophrenia	0.00216	0.00342	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—NPY—schizophrenia	0.00215	0.00341	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PPP3CC—schizophrenia	0.00212	0.00336	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FES—schizophrenia	0.00212	0.00336	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GRM2—schizophrenia	0.00212	0.00336	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TAAR6—schizophrenia	0.00212	0.00336	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PLA2G4A—schizophrenia	0.00212	0.00335	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP26B1—schizophrenia	0.00211	0.00334	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—ADORA2A—schizophrenia	0.00209	0.00331	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—OXT—schizophrenia	0.00208	0.00329	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—HTR1B—schizophrenia	0.00208	0.00329	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—schizophrenia	0.002	0.00317	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—HTR1A—schizophrenia	0.002	0.00317	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—YWHAZ—schizophrenia	0.00199	0.00315	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—NPS—schizophrenia	0.00197	0.00312	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NGEF—schizophrenia	0.00196	0.00311	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—NPY—schizophrenia	0.00195	0.0031	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—HTR2C—schizophrenia	0.00193	0.00306	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—DRD1—schizophrenia	0.00193	0.00306	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NTS—schizophrenia	0.00192	0.00304	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PLA2G4A—schizophrenia	0.00189	0.00299	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HTR1B—schizophrenia	0.00189	0.00299	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—OXT—schizophrenia	0.00189	0.00299	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—DRD3—schizophrenia	0.00187	0.00296	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HTR1A—schizophrenia	0.00181	0.00288	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—DRD4—schizophrenia	0.00181	0.00287	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RTN4—schizophrenia	0.0018	0.00286	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GRM3—schizophrenia	0.0018	0.00286	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RGS4—schizophrenia	0.0018	0.00286	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—NPS—schizophrenia	0.00179	0.00283	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—YWHAZ—schizophrenia	0.00177	0.00281	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HTR6—schizophrenia	0.00177	0.0028	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—DRD1—schizophrenia	0.00175	0.00278	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HTR2C—schizophrenia	0.00175	0.00278	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CNR1—schizophrenia	0.00173	0.00275	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—APOA1—schizophrenia	0.00172	0.00273	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MAG—schizophrenia	0.00171	0.00271	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—DRD3—schizophrenia	0.0017	0.00269	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—DRD2—schizophrenia	0.00169	0.00268	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—HTR7—schizophrenia	0.00169	0.00268	CbGpPWpGaD
Tadalafil—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—schizophrenia	0.00166	0.00263	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—DRD4—schizophrenia	0.00165	0.00261	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—NDST3—schizophrenia	0.00161	0.00256	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—schizophrenia	0.00158	0.00251	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CNR1—schizophrenia	0.00157	0.00249	CbGpPWpGaD
Tadalafil—CYP3A4—Tryptophan metabolism—CYP1A2—schizophrenia	0.00157	0.00249	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CHRM1—schizophrenia	0.00156	0.00248	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—DRD2—schizophrenia	0.00154	0.00243	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HTR7—schizophrenia	0.00154	0.00243	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—APOA1—schizophrenia	0.00153	0.00243	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL3RA—schizophrenia	0.00152	0.00241	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NRG3—schizophrenia	0.00149	0.00236	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TLE1—schizophrenia	0.00149	0.00236	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GFAP—schizophrenia	0.00147	0.00233	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GRM5—schizophrenia	0.00145	0.0023	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TLE3—schizophrenia	0.00141	0.00223	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—schizophrenia	0.00141	0.00223	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—schizophrenia	0.00139	0.0022	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCK—schizophrenia	0.00133	0.00211	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PDE4B—schizophrenia	0.0013	0.00205	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCKAR—schizophrenia	0.00127	0.00202	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—schizophrenia	0.00127	0.00201	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—schizophrenia	0.00125	0.00199	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ADORA2A—schizophrenia	0.00124	0.00196	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PLA2G4A—schizophrenia	0.00121	0.00192	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FGA—schizophrenia	0.00118	0.00188	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—HTR2A—schizophrenia	0.00118	0.00188	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NPY—schizophrenia	0.00115	0.00183	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NOTCH4—schizophrenia	0.00115	0.00183	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ATP2A2—schizophrenia	0.00115	0.00183	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—schizophrenia	0.00114	0.00181	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP26B1—schizophrenia	0.00112	0.00178	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HTR1B—schizophrenia	0.00111	0.00176	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—OXT—schizophrenia	0.00111	0.00176	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP26B1—schizophrenia	0.00111	0.00175	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HTR2A—schizophrenia	0.00108	0.0017	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HTR1A—schizophrenia	0.00107	0.0017	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NPS—schizophrenia	0.00106	0.00167	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HTR2C—schizophrenia	0.00104	0.00164	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—DRD1—schizophrenia	0.00104	0.00164	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—schizophrenia	0.00103	0.00163	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NTRK2—schizophrenia	0.00101	0.0016	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—DRD3—schizophrenia	0.001	0.00159	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GCLM—schizophrenia	0.000999	0.00158	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—EP300—schizophrenia	0.000993	0.00157	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—DRD4—schizophrenia	0.000973	0.00154	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CNR1—schizophrenia	0.000929	0.00147	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—DRD2—schizophrenia	0.000907	0.00144	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HTR7—schizophrenia	0.000907	0.00144	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—EP300—schizophrenia	0.000885	0.0014	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	0.000858	0.00136	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PRL—schizophrenia	0.000856	0.00136	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—S100B—schizophrenia	0.000798	0.00126	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ERBB4—schizophrenia	0.000763	0.00121	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PLA2G4A—schizophrenia	0.000718	0.00114	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—TP53—schizophrenia	0.00071	0.00113	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NRG1—schizophrenia	0.000704	0.00112	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MEF2C—schizophrenia	0.000698	0.00111	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—YWHAZ—schizophrenia	0.000675	0.00107	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ERBB3—schizophrenia	0.00066	0.00105	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HTR2A—schizophrenia	0.000635	0.00101	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—TP53—schizophrenia	0.000633	0.001	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP2D6—schizophrenia	0.000605	0.000959	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—AKT1—schizophrenia	0.0006	0.00095	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP2D6—schizophrenia	0.000597	0.000946	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOE—schizophrenia	0.00059	0.000935	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOA1—schizophrenia	0.000584	0.000925	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ESR1—schizophrenia	0.000564	0.000893	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP1A2—schizophrenia	0.000548	0.000868	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP1A2—schizophrenia	0.00054	0.000856	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—AKT1—schizophrenia	0.000535	0.000847	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GSK3B—schizophrenia	0.000511	0.00081	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—COMT—schizophrenia	0.000459	0.000727	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTP1—schizophrenia	0.000457	0.000724	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—MAOA—schizophrenia	0.000456	0.000722	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—COMT—schizophrenia	0.000453	0.000717	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—GSTP1—schizophrenia	0.00045	0.000714	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTM1—schizophrenia	0.00042	0.000665	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—GSTM1—schizophrenia	0.000414	0.000656	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PRODH—schizophrenia	0.000393	0.000622	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AKT1—schizophrenia	0.000379	0.000601	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AKT1—schizophrenia	0.000344	0.000545	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EP300—schizophrenia	0.000336	0.000533	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—MPC2—schizophrenia	0.00032	0.000507	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLCH2—schizophrenia	0.000298	0.000471	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NDST3—schizophrenia	0.00028	0.000443	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ACSL6—schizophrenia	0.000265	0.00042	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SLC27A5—schizophrenia	0.000265	0.00042	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—DAO—schizophrenia	0.000253	0.000401	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PNP—schizophrenia	0.000243	0.000384	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TP53—schizophrenia	0.000241	0.000382	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NDUFV2—schizophrenia	0.000226	0.000357	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIP4K2A—schizophrenia	0.000212	0.000336	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AKT1—schizophrenia	0.000203	0.000322	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP26B1—schizophrenia	0.000192	0.000304	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—TPH1—schizophrenia	0.000171	0.000271	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GCLM—schizophrenia	0.000171	0.000271	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PRKD1—schizophrenia	0.000161	0.000255	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GAPDH—schizophrenia	0.000134	0.000212	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CLOCK—schizophrenia	0.000133	0.000211	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—TPH2—schizophrenia	0.00013	0.000205	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CACNB2—schizophrenia	0.00013	0.000205	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—DPYD—schizophrenia	0.000127	0.000202	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CACNA1C—schizophrenia	0.000118	0.000188	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3C2A—schizophrenia	0.000115	0.000183	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP2D6—schizophrenia	0.000104	0.000164	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SNAP25—schizophrenia	0.000104	0.000164	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP1A2—schizophrenia	9.36e-05	0.000148	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—TH—schizophrenia	9.23e-05	0.000146	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—COMT—schizophrenia	7.85e-05	0.000124	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTP1—schizophrenia	7.81e-05	0.000124	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—MAOA—schizophrenia	7.79e-05	0.000123	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ABCB1—schizophrenia	7.39e-05	0.000117	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLA2G4A—schizophrenia	7.18e-05	0.000114	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTM1—schizophrenia	7.18e-05	0.000114	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—MTHFR—schizophrenia	6.34e-05	0.0001	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOE—schizophrenia	5.9e-05	9.36e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOA1—schizophrenia	5.84e-05	9.25e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—EP300—schizophrenia	3.37e-05	5.33e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AKT1—schizophrenia	2.03e-05	3.22e-05	CbGpPWpGaD
